| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | receptor ligand activity | IL11 NPPC WNT2B GAS6 CXCL16 CXCL1 CXCL2 CXCL3 IL27 SEMA4C VEGFB | 5.91e-06 | 547 | 75 | 11 | GO:0048018 |
| GeneOntologyMolecularFunction | signaling receptor activator activity | IL11 NPPC WNT2B GAS6 CXCL16 CXCL1 CXCL2 CXCL3 IL27 SEMA4C VEGFB | 6.67e-06 | 554 | 75 | 11 | GO:0030546 |
| GeneOntologyMolecularFunction | signaling receptor regulator activity | IL11 NPPC WNT2B GAS6 CXCL16 CXCL1 CXCL2 CXCL3 IL27 SEMA4C VEGFB | 1.80e-05 | 616 | 75 | 11 | GO:0030545 |
| GeneOntologyMolecularFunction | CXCR chemokine receptor binding | 3.99e-05 | 18 | 75 | 3 | GO:0045236 | |
| GeneOntologyMolecularFunction | chemokine activity | 4.01e-05 | 51 | 75 | 4 | GO:0008009 | |
| GeneOntologyMolecularFunction | insulin-like growth factor receptor activity | 4.17e-05 | 3 | 75 | 2 | GO:0005010 | |
| GeneOntologyMolecularFunction | cytokine activity | 4.26e-05 | 250 | 75 | 7 | GO:0005125 | |
| GeneOntologyMolecularFunction | cytoskeleton-nuclear membrane anchor activity | 1.38e-04 | 5 | 75 | 2 | GO:0140444 | |
| GeneOntologyMolecularFunction | molecular function activator activity | MMP25 IL11 NPPC TIMP2 WNT2B GAS6 CXCL16 CXCL1 CXCL2 CXCL3 TBC1D17 IL27 SEMA4C VEGFB | 1.76e-04 | 1233 | 75 | 14 | GO:0140677 |
| GeneOntologyMolecularFunction | cytokine receptor binding | 2.14e-04 | 324 | 75 | 7 | GO:0005126 | |
| GeneOntologyMolecularFunction | chemokine receptor binding | 2.45e-04 | 81 | 75 | 4 | GO:0042379 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor binding | 2.72e-04 | 337 | 75 | 7 | GO:0001664 | |
| GeneOntologyMolecularFunction | guanylate cyclase activity | 6.14e-04 | 10 | 75 | 2 | GO:0004383 | |
| GeneOntologyMolecularFunction | intracellularly cAMP-activated cation channel activity | 6.14e-04 | 10 | 75 | 2 | GO:0005222 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 7.99e-04 | 193 | 75 | 5 | GO:0015276 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 8.76e-04 | 197 | 75 | 5 | GO:0022834 | |
| GeneOntologyMolecularFunction | intracellularly cyclic nucleotide-activated monoatomic cation channel activity | 1.06e-03 | 13 | 75 | 2 | GO:0005221 | |
| GeneOntologyMolecularFunction | cyclic nucleotide-activated monoatomic ion channel activity | 1.06e-03 | 13 | 75 | 2 | GO:0043855 | |
| GeneOntologyMolecularFunction | potassium channel activity | 1.38e-03 | 128 | 75 | 4 | GO:0005267 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 1.67e-03 | 459 | 75 | 7 | GO:0005216 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 1.91e-03 | 140 | 75 | 4 | GO:0099094 | |
| GeneOntologyMolecularFunction | adenylate cyclase activity | 2.05e-03 | 18 | 75 | 2 | GO:0004016 | |
| GeneOntologyMolecularFunction | intramolecular oxidoreductase activity, transposing S-S bonds | 3.06e-03 | 22 | 75 | 2 | GO:0016864 | |
| GeneOntologyMolecularFunction | protein disulfide isomerase activity | 3.06e-03 | 22 | 75 | 2 | GO:0003756 | |
| GeneOntologyMolecularFunction | channel activity | 3.54e-03 | 525 | 75 | 7 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 3.58e-03 | 526 | 75 | 7 | GO:0022803 | |
| GeneOntologyMolecularFunction | potassium ion transmembrane transporter activity | 3.62e-03 | 167 | 75 | 4 | GO:0015079 | |
| GeneOntologyMolecularFunction | cyclase activity | 3.64e-03 | 24 | 75 | 2 | GO:0009975 | |
| GeneOntologyMolecularFunction | phosphorus-oxygen lyase activity | 3.95e-03 | 25 | 75 | 2 | GO:0016849 | |
| GeneOntologyMolecularFunction | cAMP binding | 3.95e-03 | 25 | 75 | 2 | GO:0030552 | |
| GeneOntologyMolecularFunction | cargo receptor activity | 4.03e-03 | 85 | 75 | 3 | GO:0038024 | |
| GeneOntologyMolecularFunction | growth factor activity | 4.10e-03 | 173 | 75 | 4 | GO:0008083 | |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 4.27e-03 | 26 | 75 | 2 | GO:0005248 | |
| GeneOntologyBiologicalProcess | cyclic nucleotide biosynthetic process | 1.43e-06 | 23 | 76 | 4 | GO:0009190 | |
| GeneOntologyBiologicalProcess | cGMP biosynthetic process | 1.03e-05 | 12 | 76 | 3 | GO:0006182 | |
| GeneOntologyBiologicalProcess | receptor guanylyl cyclase signaling pathway | 1.03e-05 | 12 | 76 | 3 | GO:0007168 | |
| GeneOntologyBiologicalProcess | cyclic purine nucleotide metabolic process | 2.07e-05 | 44 | 76 | 4 | GO:0052652 | |
| GeneOntologyBiologicalProcess | cyclic nucleotide metabolic process | 2.26e-05 | 45 | 76 | 4 | GO:0009187 | |
| GeneOntologyBiologicalProcess | cGMP metabolic process | 4.46e-05 | 19 | 76 | 3 | GO:0046068 | |
| GeneOntologyBiologicalProcess | regulation of cilium assembly | 4.93e-05 | 108 | 76 | 5 | GO:1902017 | |
| GeneOntologyCellularComponent | secretory granule | MMP25 NPPC IGF2R TXNDC5 TIMP2 TCP11 LILRB2 DPEP3 PRDX4 GAS6 LAMP1 CXCL1 VEGFB | 5.88e-05 | 1014 | 75 | 13 | GO:0030141 |
| GeneOntologyCellularComponent | HCN channel complex | 7.59e-05 | 4 | 75 | 2 | GO:0098855 | |
| GeneOntologyCellularComponent | postsynaptic membrane | 1.01e-04 | 405 | 75 | 8 | GO:0045211 | |
| GeneOntologyCellularComponent | secretory vesicle | MMP25 NPPC IGF2R TXNDC5 TIMP2 TCP11 LILRB2 DPEP3 PRDX4 GAS6 LAMP1 CXCL1 SEMA4C VEGFB | 1.22e-04 | 1246 | 75 | 14 | GO:0099503 |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | 1.88e-04 | 332 | 75 | 7 | GO:0005788 | |
| GeneOntologyCellularComponent | synaptic membrane | 2.34e-04 | 583 | 75 | 9 | GO:0097060 | |
| GeneOntologyCellularComponent | nuclear outer membrane | 3.98e-04 | 40 | 75 | 3 | GO:0005640 | |
| GeneOntologyCellularComponent | microtubule organizing center attachment site | 6.84e-04 | 11 | 75 | 2 | GO:0034992 | |
| GeneOntologyCellularComponent | meiotic nuclear membrane microtubule tethering complex | 6.84e-04 | 11 | 75 | 2 | GO:0034993 | |
| GeneOntologyCellularComponent | nuclear membrane protein complex | 6.84e-04 | 11 | 75 | 2 | GO:0106083 | |
| GeneOntologyCellularComponent | nuclear membrane microtubule tethering complex | 6.84e-04 | 11 | 75 | 2 | GO:0106094 | |
| GeneOntologyCellularComponent | secretory granule lumen | 1.10e-03 | 325 | 75 | 6 | GO:0034774 | |
| GeneOntologyCellularComponent | cytoplasmic vesicle lumen | 1.19e-03 | 330 | 75 | 6 | GO:0060205 | |
| GeneOntologyCellularComponent | vesicle lumen | 1.23e-03 | 332 | 75 | 6 | GO:0031983 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 2.37e-03 | 378 | 75 | 6 | GO:0034702 | |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | TPTE LPCAT2 SYNE1 GUCY2D SYNE2 SSR1 HSD11B2 IHH PTGFRN EIF2AK3 MYMX TMED3 | 2.58e-03 | 1327 | 75 | 12 | GO:0042175 |
| GeneOntologyCellularComponent | tertiary granule | 2.88e-03 | 164 | 75 | 4 | GO:0070820 | |
| GeneOntologyCellularComponent | Golgi stack | 3.35e-03 | 171 | 75 | 4 | GO:0005795 | |
| GeneOntologyCellularComponent | dendrite | 3.52e-03 | 858 | 75 | 9 | GO:0030425 | |
| GeneOntologyCellularComponent | dendritic tree | 3.58e-03 | 860 | 75 | 9 | GO:0097447 | |
| GeneOntologyCellularComponent | somatodendritic compartment | GABRD HCN4 TIMP2 SYNE1 HCN1 ADGRB1 LMTK2 LAMP1 CHRNA3 HTT SHISA8 | 4.23e-03 | 1228 | 75 | 11 | GO:0036477 |
| Domain | Chemokine_CXC | 4.21e-07 | 16 | 75 | 4 | IPR001089 | |
| Domain | SMALL_CYTOKINES_CXC | 5.49e-07 | 17 | 75 | 4 | PS00471 | |
| Domain | Chemokine_CXC_CS | 1.73e-05 | 13 | 75 | 3 | IPR018048 | |
| Domain | CXC_Chemokine_domain | 2.19e-05 | 14 | 75 | 3 | IPR033899 | |
| Domain | ER_TARGET | 3.75e-05 | 47 | 75 | 4 | PS00014 | |
| Domain | KASH | 9.50e-05 | 4 | 75 | 2 | PF10541 | |
| Domain | KASH | 9.50e-05 | 4 | 75 | 2 | IPR012315 | |
| Domain | Ion_trans_N | 9.50e-05 | 4 | 75 | 2 | PF08412 | |
| Domain | Ion_trans_N | 9.50e-05 | 4 | 75 | 2 | IPR013621 | |
| Domain | KASH | 9.50e-05 | 4 | 75 | 2 | PS51049 | |
| Domain | KASH | 9.50e-05 | 4 | 75 | 2 | SM01249 | |
| Domain | Disulphide_isomerase | 4.39e-04 | 8 | 75 | 2 | IPR005788 | |
| Domain | Thioredoxin_domain | 5.94e-04 | 41 | 75 | 3 | IPR013766 | |
| Domain | SCY | 6.38e-04 | 42 | 75 | 3 | SM00199 | |
| Domain | THIOREDOXIN_2 | 6.84e-04 | 43 | 75 | 3 | PS51352 | |
| Domain | Chemokine_IL8-like_dom | 7.32e-04 | 44 | 75 | 3 | IPR001811 | |
| Domain | IL8 | 7.32e-04 | 44 | 75 | 3 | PF00048 | |
| Domain | Laminin_G_1 | 8.55e-04 | 11 | 75 | 2 | PF00054 | |
| Domain | Ion_trans_dom | 1.15e-03 | 114 | 75 | 4 | IPR005821 | |
| Domain | Ion_trans | 1.15e-03 | 114 | 75 | 4 | PF00520 | |
| Domain | Thioredoxin | 1.21e-03 | 13 | 75 | 2 | IPR005746 | |
| Domain | K_chnl_volt-dep_EAG/ELK/ERG | 1.40e-03 | 14 | 75 | 2 | IPR003938 | |
| Domain | cNMP-bd_CS | 1.84e-03 | 16 | 75 | 2 | IPR018488 | |
| Domain | A/G_cyclase_CS | 2.08e-03 | 17 | 75 | 2 | IPR018297 | |
| Domain | Thioredoxin_CS | 2.08e-03 | 17 | 75 | 2 | IPR017937 | |
| Domain | Nucleotide_cyclase | 2.34e-03 | 18 | 75 | 2 | IPR029787 | |
| Domain | - | 2.34e-03 | 18 | 75 | 2 | 3.30.70.1230 | |
| Domain | GUANYLATE_CYCLASE_1 | 2.60e-03 | 19 | 75 | 2 | PS00452 | |
| Domain | Guanylate_cyc | 2.60e-03 | 19 | 75 | 2 | PF00211 | |
| Domain | GUANYLATE_CYCLASE_2 | 2.60e-03 | 19 | 75 | 2 | PS50125 | |
| Domain | A/G_cyclase | 2.60e-03 | 19 | 75 | 2 | IPR001054 | |
| Domain | CYCc | 2.60e-03 | 19 | 75 | 2 | SM00044 | |
| Domain | Actinin_actin-bd_CS | 3.81e-03 | 23 | 75 | 2 | IPR001589 | |
| Domain | Pentatricopeptide_repeat | 3.81e-03 | 23 | 75 | 2 | IPR002885 | |
| Domain | Spectrin | 3.81e-03 | 23 | 75 | 2 | PF00435 | |
| Domain | ACTININ_2 | 3.81e-03 | 23 | 75 | 2 | PS00020 | |
| Domain | ACTININ_1 | 3.81e-03 | 23 | 75 | 2 | PS00019 | |
| Pathway | WP_OVERVIEW_OF_PROINFLAMMATORY_AND_PROFIBROTIC_MEDIATORS | 2.12e-05 | 127 | 63 | 6 | M42533 | |
| Pathway | WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE | 2.65e-05 | 39 | 63 | 4 | MM15914 | |
| Pathway | WP_RETT_SYNDROME | 6.08e-05 | 48 | 63 | 4 | M39759 | |
| Pathway | REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES | 1.20e-04 | 57 | 63 | 4 | M625 | |
| Pathway | REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES | 1.28e-04 | 58 | 63 | 4 | MM14978 | |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | 2.01e-04 | 463 | 63 | 9 | M507 | |
| Pathway | WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE | 2.06e-04 | 26 | 63 | 3 | M39711 | |
| Pathway | REACTOME_PHYSIOLOGICAL_FACTORS | 4.07e-04 | 7 | 63 | 2 | MM15201 | |
| Pathway | REACTOME_NEUTROPHIL_DEGRANULATION | 4.17e-04 | 511 | 63 | 9 | MM15330 | |
| Pathway | REACTOME_CLASS_B_2_SECRETIN_FAMILY_RECEPTORS | 8.18e-04 | 94 | 63 | 4 | M797 | |
| Pathway | WP_CYTOKINECYTOKINE_RECEPTOR_INTERACTION | 9.28e-04 | 254 | 63 | 6 | M48344 | |
| Pubmed | FAM105A/OTULINL Is a Pseudodeubiquitinase of the OTU-Class that Localizes to the ER Membrane. | FKBP10 POGLUT3 IGF2R TXNDC5 BRI3BP LPCAT2 PRDX4 SYNE2 TMEM115 SSR1 EIF2AK3 SEMA4C | 5.11e-10 | 468 | 77 | 12 | 31056421 |
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 14583342 | ||
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 19470246 | ||
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 39135337 | ||
| Pubmed | Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19. | 1.04e-08 | 3 | 77 | 3 | 32416070 | |
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 23438680 | ||
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 16521212 | ||
| Pubmed | CXCL2 mediates lipopolysaccharide-induced osteoclastogenesis in RANKL-primed precursors. | 1.04e-08 | 3 | 77 | 3 | 21507677 | |
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 18452653 | ||
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 24659080 | ||
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 17670839 | ||
| Pubmed | Postnatal acquisition of endotoxin tolerance in intestinal epithelial cells. | 1.04e-08 | 3 | 77 | 3 | 16606665 | |
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 27883091 | ||
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 26163511 | ||
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 27241286 | ||
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 17908807 | ||
| Pubmed | CXCL2 attenuates osteoblast differentiation by inhibiting the ERK1/2 signaling pathway. | 1.04e-08 | 3 | 77 | 3 | 31292171 | |
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 34607953 | ||
| Pubmed | Nucleotide sequence of the human melanoma growth stimulatory activity (MGSA) gene. | 1.04e-08 | 3 | 77 | 3 | 2129556 | |
| Pubmed | Molecular cloning and biophysical characterization of CXCL3 chemokine. | 1.04e-08 | 3 | 77 | 3 | 28928065 | |
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 20840653 | ||
| Pubmed | Early infiltrating NKT lymphocytes attenuate bone regeneration through secretion of CXCL2. | 1.04e-08 | 3 | 77 | 3 | 38758783 | |
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 14704366 | ||
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 15829306 | ||
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 17561115 | ||
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 11907123 | ||
| Pubmed | Nitric oxide stimulates macrophage inflammatory protein-2 expression in sepsis. | 1.04e-08 | 3 | 77 | 3 | 12165537 | |
| Pubmed | Transcriptional regulation of CXC-ELR chemokines KC and MIP-2 in mouse pancreatic acini. | 1.04e-08 | 3 | 77 | 3 | 20671197 | |
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 16684516 | ||
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 12121220 | ||
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 17130903 | ||
| Pubmed | Identification of three related human GRO genes encoding cytokine functions. | 1.04e-08 | 3 | 77 | 3 | 2217207 | |
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 20234283 | ||
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 27512010 | ||
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 25762737 | ||
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 2201751 | ||
| Pubmed | Critical role of CXC chemokines in endotoxemic liver injury in mice. | 1.04e-08 | 3 | 77 | 3 | 14673016 | |
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 16855064 | ||
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 15555540 | ||
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 20065113 | ||
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 19330623 | ||
| Pubmed | Identification and characterization of macrophage inflammatory protein 2. | 1.04e-08 | 3 | 77 | 3 | 2643119 | |
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 14761936 | ||
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 15608143 | ||
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 34507947 | ||
| Pubmed | Solution structure of murine macrophage inflammatory protein-2. | 1.04e-08 | 3 | 77 | 3 | 9622482 | |
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 23234294 | ||
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 12875976 | ||
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 16863907 | ||
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 10394101 | ||
| Pubmed | 1.04e-08 | 3 | 77 | 3 | 1906501 | ||
| Pubmed | 1.56e-08 | 200 | 77 | 8 | 18240029 | ||
| Pubmed | 4.17e-08 | 4 | 77 | 3 | 36577281 | ||
| Pubmed | 4.17e-08 | 4 | 77 | 3 | 22135382 | ||
| Pubmed | 4.17e-08 | 4 | 77 | 3 | 33076328 | ||
| Pubmed | 4.17e-08 | 4 | 77 | 3 | 30201769 | ||
| Pubmed | 4.17e-08 | 4 | 77 | 3 | 17662241 | ||
| Pubmed | 4.17e-08 | 4 | 77 | 3 | 20357249 | ||
| Pubmed | 4.17e-08 | 4 | 77 | 3 | 18771438 | ||
| Pubmed | 4.17e-08 | 4 | 77 | 3 | 24632845 | ||
| Pubmed | Microglial lnc-U90926 facilitates neutrophil infiltration in ischemic stroke via MDH2/CXCL2 axis. | 4.17e-08 | 4 | 77 | 3 | 33895326 | |
| Pubmed | 4.17e-08 | 4 | 77 | 3 | 32881070 | ||
| Pubmed | 4.17e-08 | 4 | 77 | 3 | 30248108 | ||
| Pubmed | 4.17e-08 | 4 | 77 | 3 | 22564028 | ||
| Pubmed | The chemokine and chemokine receptor superfamilies and their molecular evolution. | 4.17e-08 | 4 | 77 | 3 | 17201934 | |
| Pubmed | 4.17e-08 | 4 | 77 | 3 | 18983454 | ||
| Pubmed | The Role of C-X-C Chemokines in Staphylococcus aureus Endophthalmitis. | 4.17e-08 | 4 | 77 | 3 | 36867134 | |
| Pubmed | 4.17e-08 | 4 | 77 | 3 | 16618742 | ||
| Pubmed | 4.17e-08 | 4 | 77 | 3 | 30323351 | ||
| Pubmed | 4.17e-08 | 4 | 77 | 3 | 22342618 | ||
| Pubmed | 4.17e-08 | 4 | 77 | 3 | 18347102 | ||
| Pubmed | 4.17e-08 | 4 | 77 | 3 | 20593289 | ||
| Pubmed | 4.17e-08 | 4 | 77 | 3 | 18191274 | ||
| Pubmed | 4.17e-08 | 4 | 77 | 3 | 17460147 | ||
| Pubmed | 4.17e-08 | 4 | 77 | 3 | 7961909 | ||
| Pubmed | IP-10 protects while MIP-2 promotes experimental anesthetic hapten - induced hepatitis. | 4.17e-08 | 4 | 77 | 3 | 19131211 | |
| Pubmed | 4.17e-08 | 4 | 77 | 3 | 25114117 | ||
| Pubmed | TRPM2 modulates neutrophil attraction to murine tumor cells by regulating CXCL2 expression. | 4.17e-08 | 4 | 77 | 3 | 30251149 | |
| Pubmed | CXCL1 and CXCL2 Regulate NLRP3 Inflammasome Activation via G-Protein-Coupled Receptor CXCR2. | 4.17e-08 | 4 | 77 | 3 | 28739876 | |
| Pubmed | 4.17e-08 | 4 | 77 | 3 | 38617547 | ||
| Pubmed | 4.17e-08 | 4 | 77 | 3 | 23433011 | ||
| Pubmed | 4.17e-08 | 4 | 77 | 3 | 16940143 | ||
| Pubmed | 4.17e-08 | 4 | 77 | 3 | 23393393 | ||
| Pubmed | 4.17e-08 | 4 | 77 | 3 | 17928531 | ||
| Pubmed | Fpr2/CXCL1/2 Controls Rapid Neutrophil Infiltration to Inhibit Streptococcus agalactiae Infection. | 4.17e-08 | 4 | 77 | 3 | 34899755 | |
| Pubmed | C-X-C Chemokines Influence Intraocular Inflammation During Bacillus Endophthalmitis. | 4.17e-08 | 4 | 77 | 3 | 34784411 | |
| Pubmed | The role of CXCR2 in systemic neovascularization of the mouse lung. | 4.17e-08 | 4 | 77 | 3 | 17556491 | |
| Pubmed | A model of GAG/MIP-2/CXCR2 interfaces and its functional effects. | 4.17e-08 | 4 | 77 | 3 | 22686371 | |
| Pubmed | CXCR2 ligands and G-CSF mediate PKCalpha-induced intraepidermal inflammation. | 4.17e-08 | 4 | 77 | 3 | 16964312 | |
| Pubmed | 4.17e-08 | 4 | 77 | 3 | 28662496 | ||
| Pubmed | Pneumocystis carinii activates the NF-kappaB signaling pathway in alveolar epithelial cells. | 4.17e-08 | 4 | 77 | 3 | 15845480 | |
| Pubmed | 4.17e-08 | 4 | 77 | 3 | 30446388 | ||
| Pubmed | P2X7 receptor activation induces CXCL2 production in microglia through NFAT and PKC/MAPK pathways. | 4.17e-08 | 4 | 77 | 3 | 20477948 | |
| Pubmed | 4.17e-08 | 4 | 77 | 3 | 12807894 | ||
| Pubmed | 4.17e-08 | 4 | 77 | 3 | 28053238 | ||
| Pubmed | 4.17e-08 | 4 | 77 | 3 | 17436230 | ||
| Pubmed | Syndecan-1 in the mouse parietal peritoneum microcirculation in inflammation. | 4.17e-08 | 4 | 77 | 3 | 25184228 | |
| Pubmed | TcpC secreting uropathogenic E. coli promoted kidney cells to secrete MIP-2 via p38 MAPK pathway. | 4.17e-08 | 4 | 77 | 3 | 28765918 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | FKBP10 NPR1 IGF2R TXNDC5 CRIM1 BRI3BP LPCAT2 PRDX4 NUCB1 LAMP1 SSR1 PTGFRN EIF2AK3 HTT TMED3 | 5.15e-08 | 1201 | 77 | 15 | 35696571 |
| Pubmed | Developmental expression of two CXC chemokines, MIP-2 and KC, and their receptors. | 1.04e-07 | 5 | 77 | 3 | 11444905 | |
| Interaction | CXCL3 interactions | 1.63e-07 | 14 | 74 | 4 | int:CXCL3 | |
| Interaction | FBXO2 interactions | POGLUT3 IGF2R SUSD1 SYNE2 GAS6 CTHRC1 ADAM33 PTGFRN HTT SEMA4C | 2.50e-06 | 411 | 74 | 10 | int:FBXO2 |
| Interaction | SEC61B interactions | FKBP10 POGLUT3 IGF2R TXNDC5 BRI3BP LPCAT2 SYNE1 PRDX4 SYNE2 NUCB1 SSR1 EIF2AK3 SEMA4C | 3.68e-06 | 763 | 74 | 13 | int:SEC61B |
| Interaction | SYNE3 interactions | FKBP10 POGLUT3 IGF2R TXNDC5 BRI3BP PRDX4 SYNE2 NUCB1 SSR1 EIF2AK3 | 4.97e-06 | 444 | 74 | 10 | int:SYNE3 |
| Interaction | LRRC59 interactions | FKBP10 POGLUT3 IGF2R TXNDC5 BRI3BP SYNE1 PRDX4 SYNE2 NUCB1 LAMP1 XPC SSR1 EIF2AK3 | 1.10e-05 | 845 | 74 | 13 | int:LRRC59 |
| Interaction | CALR3 interactions | 1.38e-05 | 142 | 74 | 6 | int:CALR3 | |
| Interaction | SEC62 interactions | IGF2R TXNDC5 BRI3BP LPCAT2 SYNE1 PRDX4 SYNE2 SSR1 EIF2AK3 SEMA4C | 1.55e-05 | 506 | 74 | 10 | int:SEC62 |
| Interaction | RAB3B interactions | 1.79e-05 | 310 | 74 | 8 | int:RAB3B | |
| Interaction | VAPA interactions | FKBP10 POGLUT3 TXNDC5 BRI3BP PRDX4 SYNE2 CTHRC1 LAMP1 SSR1 EIF2AK3 HTT | 3.90e-05 | 686 | 74 | 11 | int:VAPA |
| Interaction | TMT1A interactions | 5.08e-05 | 359 | 74 | 8 | int:TMT1A | |
| Interaction | PDIA4 interactions | 5.28e-05 | 468 | 74 | 9 | int:PDIA4 | |
| Interaction | CXCR1 interactions | 6.03e-05 | 21 | 74 | 3 | int:CXCR1 | |
| Interaction | DNAJC25 interactions | 8.24e-05 | 284 | 74 | 7 | int:DNAJC25 | |
| Interaction | ATP1B4 interactions | 1.14e-04 | 68 | 74 | 4 | int:ATP1B4 | |
| Interaction | CXCL1 interactions | 1.16e-04 | 26 | 74 | 3 | int:CXCL1 | |
| Interaction | OTULINL interactions | 1.18e-04 | 405 | 74 | 8 | int:OTULINL | |
| Interaction | CXCL5 interactions | 1.30e-04 | 27 | 74 | 3 | int:CXCL5 | |
| Interaction | CXCL2 interactions | 1.30e-04 | 27 | 74 | 3 | int:CXCL2 | |
| Interaction | TMEM106B interactions | 1.39e-04 | 309 | 74 | 7 | int:TMEM106B | |
| Interaction | DNAJC3 interactions | 1.83e-04 | 226 | 74 | 6 | int:DNAJC3 | |
| Interaction | TCTN1 interactions | 2.35e-04 | 151 | 74 | 5 | int:TCTN1 | |
| Interaction | CCL11 interactions | 2.62e-04 | 34 | 74 | 3 | int:CCL11 | |
| Interaction | RAB4A interactions | 2.68e-04 | 457 | 74 | 8 | int:RAB4A | |
| Interaction | EPHA10 interactions | 2.83e-04 | 86 | 74 | 4 | int:EPHA10 | |
| Interaction | CXCR2 interactions | 3.11e-04 | 36 | 74 | 3 | int:CXCR2 | |
| Cytoband | 4q21 | 5.07e-06 | 20 | 77 | 3 | 4q21 | |
| Cytoband | 19q13.33 | 3.19e-05 | 106 | 77 | 4 | 19q13.33 | |
| Cytoband | 6p24.3 | 6.28e-04 | 22 | 77 | 2 | 6p24.3 | |
| Cytoband | 16p13.3 | 7.77e-04 | 244 | 77 | 4 | 16p13.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4q13 | 2.38e-03 | 157 | 77 | 3 | chr4q13 | |
| Cytoband | 13q34 | 3.76e-03 | 54 | 77 | 2 | 13q34 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | 3.88e-03 | 1192 | 77 | 7 | chr19q13 | |
| GeneFamily | Endogenous ligands | 5.11e-08 | 237 | 57 | 9 | 542 | |
| GeneFamily | Chemokine ligands|Endogenous ligands | 1.20e-05 | 45 | 57 | 4 | 483 | |
| GeneFamily | Spectrin repeat containing nuclear envelope family | 5.84e-05 | 4 | 57 | 2 | 1252 | |
| GeneFamily | Guanylate cyclase receptors | 2.03e-04 | 7 | 57 | 2 | 343 | |
| GeneFamily | Cyclic nucleotide gated channels | 4.32e-04 | 10 | 57 | 2 | 250 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 1.46e-03 | 394 | 57 | 6 | 471 | |
| GeneFamily | Protein disulfide isomerases | 1.97e-03 | 21 | 57 | 2 | 692 | |
| GeneFamily | Endogenous ligands|Interleukins | 8.12e-03 | 43 | 57 | 2 | 601 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 1.48e-02 | 163 | 57 | 3 | 590 | |
| GeneFamily | Short chain dehydrogenase/reductase superfamily | 2.40e-02 | 76 | 57 | 2 | 743 | |
| Coexpression | NABA_MATRISOME | MMP25 IL11 CRIM1 TIMP2 WNT2B GAS6 CTHRC1 C1QC ADAM33 IHH CXCL1 CXCL2 CXCL3 SEMA4C VEGFB | 1.70e-07 | 1008 | 76 | 15 | MM17056 |
| Coexpression | NABA_MATRISOME | MMP25 IL11 CRIM1 TIMP2 WNT2B GAS6 CTHRC1 C1QC ADAM33 IHH CXCL1 CXCL2 CXCL3 SEMA4C VEGFB | 2.13e-07 | 1026 | 76 | 15 | M5889 |
| Coexpression | SOUCEK_MYC_TARGETS | 2.45e-07 | 19 | 76 | 4 | MM1252 | |
| Coexpression | ZHANG_UTERUS_C4_MYOFIBROBLAST | 1.22e-06 | 369 | 76 | 9 | MM16610 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | MMP25 IL11 TIMP2 WNT2B C1QC ADAM33 IHH CXCL1 CXCL2 CXCL3 SEMA4C VEGFB | 1.35e-06 | 738 | 76 | 12 | MM17058 |
| Coexpression | NABA_MATRISOME_ASSOCIATED | MMP25 IL11 TIMP2 WNT2B C1QC ADAM33 IHH CXCL1 CXCL2 CXCL3 SEMA4C VEGFB | 1.62e-06 | 751 | 76 | 12 | M5885 |
| Coexpression | VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN | 2.72e-06 | 135 | 76 | 6 | M5825 | |
| Coexpression | RODWELL_AGING_KIDNEY_NO_BLOOD_UP | 4.02e-06 | 224 | 76 | 7 | M9893 | |
| Coexpression | VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP | 8.05e-06 | 163 | 76 | 6 | M12112 | |
| Coexpression | LIAN_LIPA_TARGETS_6M | 9.39e-06 | 97 | 76 | 5 | MM1016 | |
| Coexpression | RODWELL_AGING_KIDNEY_UP | 1.45e-05 | 501 | 76 | 9 | M5389 | |
| Coexpression | ZHANG_UTERUS_C5_MACROPHAGE | 1.76e-05 | 187 | 76 | 6 | MM16611 | |
| Coexpression | ZHOU_INFLAMMATORY_RESPONSE_LPS_UP | 2.33e-05 | 406 | 76 | 8 | M9673 | |
| Coexpression | REN_ALVEOLAR_RHABDOMYOSARCOMA_DN | 2.37e-05 | 407 | 76 | 8 | M19541 | |
| Coexpression | GSE11961_MARGINAL_ZONE_BCELL_VS_MEMORY_BCELL_DAY40_DN | 2.57e-05 | 200 | 76 | 6 | M9327 | |
| Coexpression | GRUETZMANN_PANCREATIC_CANCER_DN | 2.57e-05 | 200 | 76 | 6 | M10431 | |
| Coexpression | RASHI_NFKB1_TARGETS | 2.58e-05 | 20 | 76 | 3 | MM1114 | |
| Coexpression | JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_DN | 2.81e-05 | 60 | 76 | 4 | M1515 | |
| Coexpression | SAUL_SEN_MAYO | 2.97e-05 | 123 | 76 | 5 | MM16098 | |
| Coexpression | ZENG_GU_ICB_CONTROL_METAGENE_44_PRECICTIVE_ICB_RESPONSE | 3.03e-05 | 206 | 76 | 6 | MM17084 | |
| Coexpression | SAUL_SEN_MAYO | 3.09e-05 | 124 | 76 | 5 | M45803 | |
| Coexpression | PHONG_TNF_TARGETS_UP | 3.41e-05 | 63 | 76 | 4 | M2496 | |
| Coexpression | MIKKELSEN_MCV6_HCP_WITH_H3K27ME3 | 3.98e-05 | 438 | 76 | 8 | M1954 | |
| Coexpression | MIKKELSEN_MCV6_HCP_WITH_H3K27ME3 | 4.11e-05 | 440 | 76 | 8 | MM832 | |
| Coexpression | GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP | 4.54e-05 | 24 | 76 | 3 | M19744 | |
| Coexpression | ZENG_GU_ICB_CONTROL_METAGENE_25_PRECICTIVE_ICB_RESPONSE | 4.96e-05 | 225 | 76 | 6 | MM17079 | |
| Coexpression | ZHANG_UTERUS_C0_SECRETORY_STROMAL3_NPPC_HIGH_CELL | 5.58e-05 | 337 | 76 | 7 | MM16606 | |
| Coexpression | NABA_SECRETED_FACTORS | 5.68e-05 | 338 | 76 | 7 | MM17064 | |
| Coexpression | TIAN_TNF_SIGNALING_VIA_NFKB | 5.81e-05 | 26 | 76 | 3 | M14435 | |
| Coexpression | GAURNIER_PSMD4_TARGETS | 6.10e-05 | 73 | 76 | 4 | M11428 | |
| Coexpression | LIAN_LIPA_TARGETS_3M | 6.10e-05 | 73 | 76 | 4 | MM1020 | |
| Coexpression | NABA_SECRETED_FACTORS | 6.23e-05 | 343 | 76 | 7 | M5883 | |
| Coexpression | ZHENG_IL22_SIGNALING_UP | 6.44e-05 | 74 | 76 | 4 | MM762 | |
| Coexpression | MURARO_PANCREAS_DUCTAL_CELL | IGF2R CRIM1 LPCAT2 TIMP2 ANKRD9 SYNE2 C1QC CXCL16 HSD11B2 CXCL1 CXCL2 CXCL3 PTGFRN | 7.09e-05 | 1276 | 76 | 13 | M39173 |
| Coexpression | DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_RESPIRATORY_SECRETORY_CELLS | 8.11e-05 | 29 | 76 | 3 | M39280 | |
| Coexpression | DESCARTES_MAIN_FETAL_ENDOCARDIAL_CELLS | 8.73e-05 | 80 | 76 | 4 | M40106 | |
| Coexpression | TRAVAGLINI_LUNG_PROLIFERATING_MACROPHAGE_CELL | POGLUT3 TIMP2 PRDX4 NUCB1 C1QC LAMP1 CXCL16 CXCL1 CXCL2 CXCL3 TMED3 | 1.05e-04 | 968 | 76 | 11 | M41693 |
| Coexpression | SEKI_INFLAMMATORY_RESPONSE_LPS_UP | 1.21e-04 | 87 | 76 | 4 | MM1253 | |
| Coexpression | GROSS_ELK3_TARGETS_DN | 1.43e-04 | 35 | 76 | 3 | MM1124 | |
| Coexpression | ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_1DY_UP | LPCAT2 SUSD1 TIMP2 LILRB2 NUCB1 GAS6 TMEM175 C1QC CXCL16 CD300C IL27 | 1.55e-04 | 1012 | 76 | 11 | M40868 |
| Coexpression | GSE6269_E_COLI_VS_STAPH_AUREUS_INF_PBMC_DN | 1.58e-04 | 175 | 76 | 5 | M5660 | |
| Coexpression | GROSS_HYPOXIA_VIA_ELK3_ONLY_UP | 1.70e-04 | 37 | 76 | 3 | MM549 | |
| Coexpression | TABULA_MURIS_SENIS_BROWN_ADIPOSE_TISSUE_T_CELL_AGEING | 1.70e-04 | 95 | 76 | 4 | MM3675 | |
| Coexpression | MEISSNER_NPC_HCP_WITH_H3_UNMETHYLATED | 1.79e-04 | 544 | 76 | 8 | M1936 | |
| Coexpression | STK33_NOMO_UP | 1.99e-04 | 290 | 76 | 6 | M2855 | |
| Coexpression | VERHAAK_AML_WITH_NPM1_MUTATED_UP | 2.15e-04 | 187 | 76 | 5 | M4861 | |
| Coexpression | GSE29615_CTRL_VS_LAIV_FLU_VACCINE_PBMC_UP | 2.43e-04 | 192 | 76 | 5 | M4923 | |
| Coexpression | CUI_DEVELOPING_HEART_VASCULAR_ENDOTHELIAL_CELL | 2.49e-04 | 193 | 76 | 5 | M39321 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_SCC_UP | 2.50e-04 | 105 | 76 | 4 | M1361 | |
| Coexpression | GHANDHI_DIRECT_IRRADIATION_UP | 2.50e-04 | 105 | 76 | 4 | M2591 | |
| Coexpression | MEISSNER_NPC_HCP_WITH_H3_UNMETHYLATED | 2.57e-04 | 574 | 76 | 8 | MM820 | |
| Coexpression | HORIUCHI_WTAP_TARGETS_UP | 2.80e-04 | 309 | 76 | 6 | M1973 | |
| Coexpression | GSE3982_BCELL_VS_CENT_MEMORY_CD4_TCELL_DN | 2.80e-04 | 198 | 76 | 5 | M5545 | |
| Coexpression | GSE22886_NAIVE_TCELL_VS_NKCELL_DN | 2.80e-04 | 198 | 76 | 5 | M4415 | |
| Coexpression | HARALAMBIEVA_PBMC_M_M_R_II_AGE_11_22YO_VACCINATED_VS_UNVACCINATED_7YR_DN | 2.86e-04 | 740 | 76 | 9 | M41202 | |
| Coexpression | GSE23321_CENTRAL_MEMORY_VS_NAIVE_CD8_TCELL_UP | 2.86e-04 | 199 | 76 | 5 | M8435 | |
| Coexpression | GSE19401_UNSTIM_VS_RETINOIC_ACID_AND_PAM2CSK4_STIM_FOLLICULAR_DC_UP | 2.93e-04 | 200 | 76 | 5 | M7665 | |
| Coexpression | GSE5589_LPS_VS_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_UP | 2.93e-04 | 200 | 76 | 5 | M6611 | |
| Coexpression | GSE5679_CTRL_VS_PPARG_LIGAND_ROSIGLITAZONE_AND_RARA_AGONIST_AM580_TREATED_DC_DN | 2.93e-04 | 200 | 76 | 5 | M6560 | |
| Coexpression | GSE29618_MONOCYTE_VS_MDC_DAY7_FLU_VACCINE_UP | 2.93e-04 | 200 | 76 | 5 | M4966 | |
| Coexpression | GSE17721_CTRL_VS_LPS_0.5H_BMDC_DN | 2.93e-04 | 200 | 76 | 5 | M3680 | |
| Coexpression | SIMBULAN_UV_RESPONSE_NORMAL_UP | 2.95e-04 | 9 | 76 | 2 | M16664 | |
| Coexpression | TRAVAGLINI_LUNG_MACROPHAGE_CELL | 3.00e-04 | 201 | 76 | 5 | M41692 | |
| Coexpression | TRAVAGLINI_LUNG_IGSF21_DENDRITIC_CELL | 3.25e-04 | 46 | 76 | 3 | M41696 | |
| Coexpression | NIKOLSKY_BREAST_CANCER_16P13_AMPLICON | 4.03e-04 | 119 | 76 | 4 | M1788 | |
| Coexpression | GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP | 4.12e-04 | 616 | 76 | 8 | MM977 | |
| Coexpression | ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP | 4.82e-04 | 223 | 76 | 5 | M19826 | |
| Coexpression | ZHANG_UTERUS_C10_STROMAL2_RETNLG_HIGH_CELL | 5.22e-04 | 54 | 76 | 3 | MM16616 | |
| Coexpression | TABULA_MURIS_SENIS_SPLEEN_MACROPHAGE_AGEING | 5.30e-04 | 128 | 76 | 4 | MM3838 | |
| Coexpression | TABULA_MURIS_SENIS_MAMMARY_GLAND_STROMAL_CELL_AGEING | 5.33e-04 | 349 | 76 | 6 | MM3790 | |
| Coexpression | POS_RESPONSE_TO_HISTAMINE_UP | 5.37e-04 | 12 | 76 | 2 | M1782 | |
| Coexpression | TABULA_MURIS_SENIS_MAMMARY_GLAND_LUMINAL_EPITHELIAL_CELL_OF_MAMMARY_GLAND_AGEING | 5.58e-04 | 352 | 76 | 6 | MM3788 | |
| Coexpression | GSE12707_AT16L1_HYPOMORPH_VS_WT_THYMUS_DN | 5.62e-04 | 130 | 76 | 4 | M434 | |
| Coexpression | CROONQUIST_STROMAL_STIMULATION_UP | 5.81e-04 | 56 | 76 | 3 | M5929 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_OMD_POS_ENDOTHELIAL_CELL | 5.83e-04 | 355 | 76 | 6 | M45758 | |
| Coexpression | TABULA_MURIS_SENIS_BRAIN_MYELOID_MICROGLIAL_CELL_AGEING | 5.92e-04 | 356 | 76 | 6 | MM3684 | |
| Coexpression | GSE9946_MATURE_STIMULATORY_VS_LISTERIA_INF_MATURE_DC_DN | 5.96e-04 | 132 | 76 | 4 | M425 | |
| Coexpression | TABULA_MURIS_SENIS_BROWN_ADIPOSE_TISSUE_MYELOID_CELL_AGEING | 6.72e-04 | 240 | 76 | 5 | MM3678 | |
| Coexpression | NABA_MATRISOME_HGSOC_OMENTAL_METASTASIS | 6.78e-04 | 59 | 76 | 3 | M47993 | |
| Coexpression | ONDER_CDH1_TARGETS_3_DN | 6.78e-04 | 59 | 76 | 3 | M11790 | |
| Coexpression | DASU_IL6_SIGNALING_UP | 7.47e-04 | 61 | 76 | 3 | M14344 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_DN | 7.94e-04 | 681 | 76 | 8 | M5314 | |
| Coexpression | HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP | 8.21e-04 | 63 | 76 | 3 | M9775 | |
| Coexpression | BILD_HRAS_ONCOGENIC_SIGNATURE | 8.37e-04 | 252 | 76 | 5 | M12029 | |
| Coexpression | HINATA_NFKB_IMMU_INF | 8.50e-04 | 15 | 76 | 2 | M2645 | |
| Coexpression | GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP | 8.60e-04 | 64 | 76 | 3 | M4406 | |
| Coexpression | TABULA_MURIS_SENIS_HEART_MONOCYTE_AGEING | 8.91e-04 | 147 | 76 | 4 | MM3707 | |
| Coexpression | ENK_UV_RESPONSE_KERATINOCYTE_UP | 9.01e-04 | 533 | 76 | 7 | M10791 | |
| Coexpression | P53_DN.V2_UP | 9.13e-04 | 148 | 76 | 4 | M2694 | |
| ToppCell | 10x5'-bone_marrow-Myeloid_Mac-Intermediate_macrophages|bone_marrow / Manually curated celltypes from each tissue | 2.19e-08 | 174 | 77 | 7 | 268abfc4d53a3ba3931dbcafffef09a72ea0edfa | |
| ToppCell | 10x5'-GI_small-bowel-Myeloid_Mac-Intestinal_macrophages|GI_small-bowel / Manually curated celltypes from each tissue | 4.97e-08 | 196 | 77 | 7 | 075e5746fa5cb121115a1d51b823c0fbf8d54305 | |
| ToppCell | (6)_Macrophage|World / shred on Cell_type and subtype | 5.15e-08 | 197 | 77 | 7 | 010b275d4da4a896175ad7fbaa96d1dc11a0b744 | |
| ToppCell | Monocytes-Phagocytic_CD16+_macrophages|World / Immune cells in Kidney/Urine in Lupus Nephritis | 5.33e-08 | 198 | 77 | 7 | 09009cc966bf1503c3b15dfa079a6c5f6ad1f507 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Hematopoietic-Myeloid|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.33e-08 | 198 | 77 | 7 | af682919a874d60f579e854c274dc47063015ea9 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic-Classical_Monocyte|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.33e-08 | 198 | 77 | 7 | 94e2567f057b2c455a9656b121321a28e7cb1d2b | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.33e-08 | 198 | 77 | 7 | f3a12a7e23bb4ff6e82fee675dbc090d99587f69 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.51e-08 | 199 | 77 | 7 | 6783d571d28eac891fcc70380f176b53f35c88ba | |
| ToppCell | Transverse-Macrophage-Macrophage|Transverse / Region, Cell class and subclass | 5.71e-08 | 200 | 77 | 7 | 17548806ba38008050244151d1216c69ef8a8310 | |
| ToppCell | Transverse-(6)_Macrophage|Transverse / shred on region, Cell_type, and subtype | 5.71e-08 | 200 | 77 | 7 | b28350de555fa756d2631f004f71d5ac69b1affe | |
| ToppCell | Sigmoid-(4)_Monocyte|Sigmoid / shred on region, Cell_type, and subtype | 5.71e-08 | 200 | 77 | 7 | 7f3920a0434d5199c6c8f0b3064a305bb0d87b60 | |
| ToppCell | Sigmoid-Monocyte-Monocyte|Sigmoid / Region, Cell class and subclass | 5.71e-08 | 200 | 77 | 7 | 010ca36970cb8894bdbca08779c0ecf56be22fc9 | |
| ToppCell | Sigmoid-Monocyte|Sigmoid / Region, Cell class and subclass | 5.71e-08 | 200 | 77 | 7 | c41bd6ec0f2262fce5cadb37a400d487e6662f49 | |
| ToppCell | Transverse-Macrophage|Transverse / Region, Cell class and subclass | 5.71e-08 | 200 | 77 | 7 | 1920605e5811938814d02b971069a4506868db5f | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-mo-Mac|Myeloid_cells / Location, Cell class and cell subclass | 5.71e-08 | 200 | 77 | 7 | 4758b96725699641b55a665533adf2d238032b09 | |
| ToppCell | Sigmoid-(4)_Monocyte-(40)_Monocyte|Sigmoid / shred on region, Cell_type, and subtype | 5.71e-08 | 200 | 77 | 7 | 576c0a1098e6a934448705de3673ef798fcf1b26 | |
| ToppCell | Transverse-(6)_Macrophage-(60)_Macrophage|Transverse / shred on region, Cell_type, and subtype | 5.71e-08 | 200 | 77 | 7 | 2be675684a2958ea609939bb45248bede78a26bc | |
| ToppCell | Myeloid-Myeloid-E_(Neutrophils)|Myeloid / shred on cell class and cell subclass (v4) | 2.42e-07 | 150 | 77 | 6 | 1bffb8d86b737ac43be902d9468041aef3542f1f | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-interstitial_macrophage-interstitial_macrophage_l12|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.72e-07 | 168 | 77 | 6 | aaafa7243c44e6852d92e3445335fc4a1018f416 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-CD163+CD14+_DCs|normal_Lymph_Node / Location, Cell class and cell subclass | 5.60e-07 | 173 | 77 | 6 | 38f88f5bbf92a3bf5109bc4782cd071b7cb1ca34 | |
| ToppCell | 15-Trachea-Mesenchymal-Mesenchyme_RSPO2+|Trachea / Age, Tissue, Lineage and Cell class | 5.80e-07 | 174 | 77 | 6 | fa0681e91724b9a51ee28b214ea5aa14e62ba1a3 | |
| ToppCell | PCW_10-12-Hematologic_Myeloid-Hem_Myeloid_macrophage-im_macrophage_(16)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 6.20e-07 | 176 | 77 | 6 | 98176bf3c961d5262593e2d5d002836adb010e13 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-interstitial_macrophage|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.62e-07 | 178 | 77 | 6 | c85de851b39cb8ef7ea1866ab64c6a387788273a | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Dendritic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.84e-07 | 179 | 77 | 6 | 8bd85ee92791996377bcafed198c1bb3c9af4c3c | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Monocytic-Nonclassical_Monocyte|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.84e-07 | 179 | 77 | 6 | 6624a2e731ab2d6c2eec19445e3dc509f581a8a9 | |
| ToppCell | normal_Pleural_Fluid-Myeloid_cells-mo-Mac|normal_Pleural_Fluid / Location, Cell class and cell subclass | 6.84e-07 | 179 | 77 | 6 | cd3c58e044f5a38e815313a1636153d81a592fce | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-interstitial_macrophage-interstitial_macrophage_33|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.84e-07 | 179 | 77 | 6 | 13d80ae2e43a5daad0aeb5f47338efca2c58800a | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Mac-Intestinal_macrophages|lymph-node_spleen / Manually curated celltypes from each tissue | 7.07e-07 | 180 | 77 | 6 | 7be7d7a6906fff6dbdecd9cb013d855aba4eda2a | |
| ToppCell | 3'-Child09-12-SmallIntestine-Hematopoietic-Myeloid-Macrophages|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.07e-07 | 180 | 77 | 6 | 7af90f0e7ca001bf1fe5c860ee54c4cc8eb483bf | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.11e-07 | 188 | 77 | 6 | 5f6ad5d693145d846ca561c2fa55465a88e40b90 | |
| ToppCell | PCW_10-12-Hematologic_Myeloid-Hem_Myeloid_macrophage|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 9.39e-07 | 189 | 77 | 6 | 440c422369de1c49112d18cf8c506a2a3a81f6ba | |
| ToppCell | mild-Lymphocytic-CD4_T_cells_2|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.03e-06 | 192 | 77 | 6 | 4cd8f572e067bf5fe22f62fa868d7d332f097a8c | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.06e-06 | 193 | 77 | 6 | 2ebb950476767f330241b0077ced22e55e124359 | |
| ToppCell | IIH-mono3-|IIH / Condition, Cell_class and T cell subcluster | 1.13e-06 | 195 | 77 | 6 | 28a858b04a7b413916c07a8d880f5ea02e985461 | |
| ToppCell | COVID-19_Severe|World / Disease condition and Cell class | 1.13e-06 | 195 | 77 | 6 | 22f56ccb81967bff54a1f90e949a8dfc2ce0e4ab | |
| ToppCell | IIH-mono3|IIH / Condition, Cell_class and T cell subcluster | 1.13e-06 | 195 | 77 | 6 | c6dd5af582d257be64b718e30f60220c1bf1738a | |
| ToppCell | (2)_5-FU|World / Stress and Cell class | 1.13e-06 | 195 | 77 | 6 | e5b1d96fafeb2f3b1f4cdf6b2c9eddef36bca7ff | |
| ToppCell | COVID-19_Severe-Non-classical_Monocyte|COVID-19_Severe / disease group, cell group and cell class | 1.16e-06 | 196 | 77 | 6 | af9e8f5ef9d03862f707e105857309b55595b1b9 | |
| ToppCell | ILEUM-inflamed-(3)_Resident_macrophages|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.16e-06 | 196 | 77 | 6 | 5ac246a823a8e1996325753858615269687b429d | |
| ToppCell | ILEUM-inflamed-(3)_Inf._Macrophages|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.16e-06 | 196 | 77 | 6 | 6ba84bc229e80b4e71c59301154d165066dd618c | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c5-CD16|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.16e-06 | 196 | 77 | 6 | 51fc8bb9a806f8fbf78d5d80d535f1068a9770c2 | |
| ToppCell | ILEUM-non-inflamed-(3)_Resident_macrophages|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.20e-06 | 197 | 77 | 6 | 3af24354b6a93c7d105b9fa6549cf215107b9203 | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Monocytic-Nonclassical_monocytes|lymph-node_spleen / Manually curated celltypes from each tissue | 1.20e-06 | 197 | 77 | 6 | 67f19dd30adb03300f04219d0295bc1c1788f626 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c4-CD14-CD16|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.20e-06 | 197 | 77 | 6 | 989eaf7ecef8683e3ec6ec024fd193a2f5861b26 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-Myeloid-Monocytes|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.20e-06 | 197 | 77 | 6 | d9d58c2fe40d9b5b9031fb7a71525a535927effe | |
| ToppCell | (7)_MNP|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.20e-06 | 197 | 77 | 6 | 6790346736946984cc80d67668523ba70ab0b380 | |
| ToppCell | mild_COVID-19-Non-classical_Monocyte|mild_COVID-19 / disease group, cell group and cell class (v2) | 1.23e-06 | 198 | 77 | 6 | d7620b8d24e04ce1c563fc0ebe1625e03fe78950 | |
| ToppCell | VE-mono1-|VE / Condition, Cell_class and T cell subcluster | 1.23e-06 | 198 | 77 | 6 | 2959d6e4992c36040ec9637f5a2daed02b35cf30 | |
| ToppCell | VE-mono1|VE / Condition, Cell_class and T cell subcluster | 1.23e-06 | 198 | 77 | 6 | c742871b8ec4720b1848991551c7c1f4000ebd85 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-fibroblastic-Stromal_4_(MMP1+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.23e-06 | 198 | 77 | 6 | 229588189825b1080181db9515185677b742c668 | |
| ToppCell | 10x5'-GI_small-bowel-Myeloid_Mac|GI_small-bowel / Manually curated celltypes from each tissue | 1.23e-06 | 198 | 77 | 6 | 748db69d3c9774e44c0cc425d937d18b83af8312 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-06 | 198 | 77 | 6 | b086af292a508a156266c2d899ba1caf820bf61c | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-06 | 198 | 77 | 6 | 1b90d632e59c3c47b936e829cceeb0334f05f34f | |
| ToppCell | (4)_Monocyte|World / shred on Cell_type and subtype | 1.23e-06 | 198 | 77 | 6 | 56f9ebf902fe81c590696ba4c88028deaf346841 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells|normal_Lymph_Node / Location, Cell class and cell subclass | 1.23e-06 | 198 | 77 | 6 | 6b956073898192b1c6c8da66416b6a9b20d28a82 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-06 | 198 | 77 | 6 | 524305c5d7b1d53e86ec0af775efefa3e0955e47 | |
| ToppCell | mLN-B_cell-B_cell_IgA_Plasma|B_cell / Region, Cell class and subclass | 1.27e-06 | 199 | 77 | 6 | 09494953bc7fff63cf2763ea89fca7abb97c186f | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_macrophage|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.27e-06 | 199 | 77 | 6 | bcf7d15b6a08b24e7dd0ce106817659cb976f833 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.27e-06 | 199 | 77 | 6 | c4fc638a8dad3a9b77634e8912a9326c8a2f11f5 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-myeloid|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.27e-06 | 199 | 77 | 6 | 0f3ce61bbae69f7e333ed8dacf7257645624e163 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic-Classical_Monocyte-Mono_c2-CD14-HLA-DPB1|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.27e-06 | 199 | 77 | 6 | 97af159fa3a5533ec3d45331fb80c6da8a715aa5 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_MHC|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.27e-06 | 199 | 77 | 6 | 928a3dbef54a2c292a71edb398d64dd54c259164 | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.27e-06 | 199 | 77 | 6 | 80ed217d28ba1c07facd0e103c25a02658dd848d | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c4-CD14-CD16|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.27e-06 | 199 | 77 | 6 | 18b6087863fda22e3e2a2167e7daeb347df1d95b | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.27e-06 | 199 | 77 | 6 | 697a9a58c0cdb77222700d029873355d37f6ab28 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_macrophage-macrophage|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.31e-06 | 200 | 77 | 6 | bc56d6d6d32405685e9bd553ebdbe48b8fbe6902 | |
| ToppCell | Sigmoid-(6)_Macrophage-(61)_LYVE1_Macrophage|Sigmoid / shred on region, Cell_type, and subtype | 1.31e-06 | 200 | 77 | 6 | bc0280d52e4edc2c5edf4ead164a1c7cf3fccd60 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.31e-06 | 200 | 77 | 6 | c325dc52e4bf3829a35905b956784ca3e9191926 | |
| ToppCell | Caecum-Macrophage-Macrophage|Caecum / Region, Cell class and subclass | 1.31e-06 | 200 | 77 | 6 | 99dcf07b17ecf90d596f3b8a12d5b7aae2a351d5 | |
| ToppCell | Sigmoid-Macrophage|Sigmoid / Region, Cell class and subclass | 1.31e-06 | 200 | 77 | 6 | b07ac0ff3b8530e99094678fed80f35949cafac8 | |
| ToppCell | Caecum-(6)_Macrophage-(60)_Macrophage|Caecum / shred on region, Cell_type, and subtype | 1.31e-06 | 200 | 77 | 6 | 67b6cdeb07ffc5c9af7a3e738dd31256cf391e98 | |
| ToppCell | Sigmoid-Macrophage-LYVE1_Macrophage|Sigmoid / Region, Cell class and subclass | 1.31e-06 | 200 | 77 | 6 | 851a1b372ddbec522829069e69ed36a1f4832131 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_macrophage|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.31e-06 | 200 | 77 | 6 | d08c0b10cd95bfb462792e368627b3e36582b263 | |
| ToppCell | Caecum-(6)_Macrophage|Caecum / shred on region, Cell_type, and subtype | 1.31e-06 | 200 | 77 | 6 | 2ce3930645c3daf6be578f7881e57a58df61e75c | |
| ToppCell | Caecum-Macrophage|Caecum / Region, Cell class and subclass | 1.31e-06 | 200 | 77 | 6 | d83209559187a4419df2508ecc5eb9f7d72fced3 | |
| ToppCell | Sigmoid-(6)_Macrophage|Sigmoid / shred on region, Cell_type, and subtype | 1.31e-06 | 200 | 77 | 6 | 9e10cca4429de2c4c8c3c6cf2c9e28637a095be9 | |
| ToppCell | ILEUM-inflamed-(8)_Fibroblast-(8)_Activated_fibroblasts|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.31e-06 | 200 | 77 | 6 | 2518d1758e2730b028270e76b949cebbeb7fb5ce | |
| ToppCell | Lung_Parenchyma|World / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.34e-06 | 201 | 77 | 6 | 91ec5eebe93a3c7b1a33c27e5da949b123b676a8 | |
| ToppCell | (60)_Macrophage|World / shred on Cell_type and subtype | 1.46e-06 | 204 | 77 | 6 | 06d0cb306f1ad0014d81f8228868938e48c2bcf3 | |
| ToppCell | (30)_ILC|World / shred on Cell_type and subtype | 1.46e-06 | 204 | 77 | 6 | bd9fbd278c05e396463704d711b60d47699e3c09 | |
| ToppCell | (40)_Monocyte|World / shred on Cell_type and subtype | 1.55e-06 | 206 | 77 | 6 | d78a70f951265ef6df8f64404107be4f53e75d28 | |
| ToppCell | facs-Marrow-T-cells-24m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.32e-06 | 145 | 77 | 5 | 4f8b188a93a038afbc7a446df8467ad544f5b1cb | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c5-CD16|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.33e-06 | 159 | 77 | 5 | 210ac7fa89514a84f38d9f42254e38fbc2bc5f42 | |
| ToppCell | droplet-Kidney-nan-18m-Myeloid-CD45____macrophage|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.58e-06 | 160 | 77 | 5 | d18c4cc99a31481dd0ee8af9299695d5f6857b42 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic-Nonclassical_Monocyte|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.58e-06 | 160 | 77 | 5 | c9fe3438f747e2a98e3f27a56ba4c12a3789c2f2 | |
| ToppCell | droplet-Kidney-nan-18m-Myeloid|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.58e-06 | 160 | 77 | 5 | a707a4ad9fbedcca227f76b49f1393e88101c2fb | |
| ToppCell | droplet-Kidney-nan-18m-Myeloid-macrophage|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.58e-06 | 160 | 77 | 5 | 73b604cbdcd9e8f0f317964abc632abee314a557 | |
| ToppCell | droplet-Kidney-nan-21m-Myeloid-CD45____macrophage|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.68e-06 | 164 | 77 | 5 | d4cdcd61e8c28b3fb912cef8837cc1a49678a729 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Myeloid-macrophage|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.68e-06 | 164 | 77 | 5 | e19fc6ba049336ab989a3a968bdbefd567971d73 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Myeloid|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.68e-06 | 164 | 77 | 5 | d6526551d0b183c3ef027ba3dbfddeac03fd93bb | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Myeloid-Granulocytic-Neutrophil|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.68e-06 | 164 | 77 | 5 | 10741c7706a37b24aa08a300b27d60d6b8600167 | |
| ToppCell | 356C-Myeloid-Dendritic-pDC|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 9.68e-06 | 164 | 77 | 5 | fed26f4ac36a2b0722bc7b9f91659c5e0cf4d53a | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Myeloid-CD45____macrophage|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.68e-06 | 164 | 77 | 5 | eba25e4d65ca66b5192a7a4d11423f3fa0956828 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Myeloid-Granulocytic|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.68e-06 | 164 | 77 | 5 | 7077683afee91828ad2b95e0f81c2b27aae0f831 | |
| ToppCell | droplet-Kidney-nan-21m-Myeloid-macrophage|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.96e-06 | 165 | 77 | 5 | 9852a4cb680af39c92c7d2d5e5fa8dc04e6602aa | |
| ToppCell | droplet-Kidney-nan-21m-Myeloid|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.96e-06 | 165 | 77 | 5 | c629ed33ff14834c32cc1a91116fb079f7aaa94d | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-cDC2|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.03e-05 | 166 | 77 | 5 | 83d0c26ccee605df6b04bbca31661bf4ff4f22ba | |
| ToppCell | droplet-Kidney-nan-3m-Myeloid|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-05 | 166 | 77 | 5 | 961f93f7fb127f449cb1021f6ba73775dc666c53 | |
| ToppCell | droplet-Kidney-nan-3m-Myeloid-macrophage|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-05 | 166 | 77 | 5 | fc71e871084299fb6f006c76f91e72026a290149 | |
| ToppCell | droplet-Kidney-nan-3m-Myeloid-CD45____macrophage|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-05 | 166 | 77 | 5 | f55fc58572ae6080ac2758462a6b1f3f8b5a93f3 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 8.15e-05 | 50 | 50 | 4 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_HYPOXIA | |
| Drug | 17alpha-estradiol | MMP25 GABRD IL11 NPR1 IGF2R CD7 TIMP2 TELO2 GUCY2D SHBG PDIA2 HSD11B2 IHH CXCL1 CXCL2 CXCL3 CHRNA3 VEGFB | 2.50e-07 | 1303 | 77 | 18 | CID000000450 |
| Drug | Nimodipine [66085-59-4]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 3.31e-07 | 196 | 77 | 8 | 6480_UP | |
| Drug | O-Su | 1.83e-06 | 60 | 77 | 5 | CID000447970 | |
| Drug | Practolol [6673-35-4]; Up 200; 15uM; PC3; HT_HG-U133A | 4.86e-06 | 198 | 77 | 7 | 4603_UP | |
| Drug | CP-320650-01 [172079-28-6]; Down 200; 10uM; MCF7; HT_HG-U133A | 5.19e-06 | 200 | 77 | 7 | 4379_DN | |
| Drug | aldosterone | 7.71e-06 | 397 | 77 | 9 | CID000005839 | |
| Drug | FS-2 | 8.00e-06 | 12 | 77 | 3 | CID003042059 | |
| Drug | AC1NBL8T | 8.64e-06 | 82 | 77 | 5 | CID004469804 | |
| Drug | Toxins, Biological | 8.77e-06 | 632 | 77 | 11 | ctd:D014118 | |
| Drug | Mefloquine hydrochloride [51773-92-3]; Up 200; 9.6uM; PC3; HT_HG-U133A | 2.35e-05 | 169 | 77 | 6 | 5724_UP | |
| Drug | Peptide 78 | 2.88e-05 | 105 | 77 | 5 | CID003081257 | |
| Drug | Croton Oil | 3.36e-05 | 54 | 77 | 4 | ctd:D003436 | |
| Drug | Promethazine hydrochloride [58-33-3]; Down 200; 12.4uM; HL60; HT_HG-U133A | 4.94e-05 | 193 | 77 | 6 | 3100_DN | |
| Drug | Clemastine fumarate [14976-57-9]; Up 200; 8.6uM; HL60; HT_HG-U133A | 4.94e-05 | 193 | 77 | 6 | 2412_UP | |
| Drug | Nafcillin sodium salt monohydrate [7177-50-6]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 5.23e-05 | 195 | 77 | 6 | 4103_DN | |
| Drug | Lidoflazine [3416-26-0]; Up 200; 8.2uM; MCF7; HT_HG-U133A | 5.53e-05 | 197 | 77 | 6 | 3201_UP | |
| Drug | Ifenprodil tartrate [23210-58-4]; Up 200; 8.4uM; HL60; HT_HG-U133A | 5.69e-05 | 198 | 77 | 6 | 2372_UP | |
| Drug | Chlorzoxazone [95-25-0]; Down 200; 23.6uM; PC3; HT_HG-U133A | 5.69e-05 | 198 | 77 | 6 | 2100_DN | |
| Drug | Niridazole [61-57-4]; Up 200; 18.6uM; PC3; HT_HG-U133A | 5.69e-05 | 198 | 77 | 6 | 4621_UP | |
| Drug | isopropanol | 5.91e-05 | 122 | 77 | 5 | CID000003776 | |
| Drug | Etifenin [63245-28-3]; Down 200; 12.4uM; MCF7; HT_HG-U133A | 6.02e-05 | 200 | 77 | 6 | 2838_DN | |
| Drug | 2,3-pentanedione | 7.70e-05 | 129 | 77 | 5 | ctd:C013186 | |
| Drug | lipopolysaccharide, Helicobacter pylori | 8.11e-05 | 25 | 77 | 3 | ctd:C442865 | |
| Drug | CAS 80474-14-2 | 8.28e-05 | 131 | 77 | 5 | CID000003399 | |
| Disease | viral pneumonia (biomarker_via_orthology) | 1.51e-08 | 3 | 74 | 3 | DOID:10533 (biomarker_via_orthology) | |
| Disease | aspiration pneumonia (biomarker_via_orthology) | 3.01e-07 | 6 | 74 | 3 | DOID:0050152 (biomarker_via_orthology) | |
| Disease | esophageal cancer (biomarker_via_orthology) | 3.01e-07 | 6 | 74 | 3 | DOID:5041 (biomarker_via_orthology) | |
| Disease | severe acute respiratory syndrome (biomarker_via_orthology) | 8.40e-07 | 8 | 74 | 3 | DOID:2945 (biomarker_via_orthology) | |
| Disease | vitamin D-dependent rickets (implicated_via_orthology) | 8.40e-07 | 8 | 74 | 3 | DOID:0080883 (implicated_via_orthology) | |
| Disease | pneumonia (biomarker_via_orthology) | 2.46e-06 | 11 | 74 | 3 | DOID:552 (biomarker_via_orthology) | |
| Disease | bronchopulmonary dysplasia (biomarker_via_orthology) | 3.28e-06 | 12 | 74 | 3 | DOID:11650 (biomarker_via_orthology) | |
| Disease | prostatitis (biomarker_via_orthology) | 3.28e-06 | 12 | 74 | 3 | DOID:14654 (biomarker_via_orthology) | |
| Disease | bacterial pneumonia (biomarker_via_orthology) | 5.40e-06 | 14 | 74 | 3 | DOID:874 (biomarker_via_orthology) | |
| Disease | sick sinus syndrome (implicated_via_orthology) | 1.86e-05 | 3 | 74 | 2 | DOID:13884 (implicated_via_orthology) | |
| Disease | Coronavirus infectious disease (biomarker_via_orthology) | 1.86e-05 | 3 | 74 | 2 | DOID:0080599 (biomarker_via_orthology) | |
| Disease | dilated cardiomyopathy (biomarker_via_orthology) | 2.25e-05 | 22 | 74 | 3 | DOID:12930 (biomarker_via_orthology) | |
| Disease | Autosomal dominant Emery-Dreifuss muscular dystrophy | 3.71e-05 | 4 | 74 | 2 | cv:CN293514 | |
| Disease | acute necrotizing pancreatitis (biomarker_via_orthology) | 3.78e-05 | 26 | 74 | 3 | DOID:0080998 (biomarker_via_orthology) | |
| Disease | Autosomal Recessive Emery-Dreifuss Muscular Dystrophy | 6.17e-05 | 5 | 74 | 2 | C1450051 | |
| Disease | Autosomal Dominant Emery-Dreifuss Muscular Dystrophy (disorder) | 6.17e-05 | 5 | 74 | 2 | C0410190 | |
| Disease | Emery-Dreifuss muscular dystrophy | 9.25e-05 | 6 | 74 | 2 | cv:C0410189 | |
| Disease | Muscular Dystrophy, Emery-Dreifuss | 9.25e-05 | 6 | 74 | 2 | C0410189 | |
| Disease | lung disease (biomarker_via_orthology) | 9.35e-05 | 35 | 74 | 3 | DOID:850 (biomarker_via_orthology) | |
| Disease | status epilepticus (biomarker_via_orthology) | 1.19e-04 | 100 | 74 | 4 | DOID:1824 (biomarker_via_orthology) | |
| Disease | Shock, Hemorrhagic | 1.29e-04 | 7 | 74 | 2 | C0036982 | |
| Disease | X-Linked Emery-Dreifuss Muscular Dystrophy | 1.29e-04 | 7 | 74 | 2 | C0751337 | |
| Disease | schizophrenia, type 2 diabetes mellitus | 1.74e-04 | 43 | 74 | 3 | MONDO_0005090, MONDO_0005148 | |
| Disease | Generalized Epilepsy with Febrile Seizures Plus | 2.21e-04 | 9 | 74 | 2 | C3502809 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 2.43e-04 | 222 | 74 | 5 | EFO_0008317, EFO_0020943 | |
| Disease | triglycerides in LDL measurement | 3.81e-04 | 56 | 74 | 3 | EFO_0022320 | |
| Disease | Bronchial Hyperreactivity | 4.03e-04 | 12 | 74 | 2 | C0085129 | |
| Disease | Emery-Dreifuss muscular dystrophy (implicated_via_orthology) | 4.03e-04 | 12 | 74 | 2 | DOID:11726 (implicated_via_orthology) | |
| Disease | chronic obstructive pulmonary disease (is_implicated_in) | 5.40e-04 | 63 | 74 | 3 | DOID:3083 (is_implicated_in) | |
| Disease | C-X-C motif chemokine 6 measurement | 7.28e-04 | 16 | 74 | 2 | EFO_0008059 | |
| Disease | Cardiac Hypertrophy | 1.16e-03 | 82 | 74 | 3 | C1383860 | |
| Disease | Cardiomegaly | 1.16e-03 | 82 | 74 | 3 | C0018800 | |
| Disease | type 1 diabetes mellitus (is_implicated_in) | 1.29e-03 | 85 | 74 | 3 | DOID:9744 (is_implicated_in) | |
| Disease | level of Sphingomyelin (d40:2) in blood serum | 1.52e-03 | 23 | 74 | 2 | OBA_2045181 | |
| Disease | brain stem volume measurement | 1.65e-03 | 24 | 74 | 2 | EFO_0010605 | |
| Disease | Edema | 1.94e-03 | 26 | 74 | 2 | C0013604 | |
| Disease | Anasarca | 1.94e-03 | 26 | 74 | 2 | C0151603 | |
| Disease | hemoglobin A1 measurement | 1.96e-03 | 520 | 74 | 6 | EFO_0007629 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RLLLLPLLLALARGL | 6 | P09564 | |
| ARAGLLLLLLLLLLL | 11 | Q8WY22 | |
| CLLLRLLRQLLTLLR | 96 | Q8N9T2 | |
| QRLRGLLLLLLLQLP | 11 | Q96CG8 | |
| SPGLLVRALLLLLLL | 6 | Q9NZJ5 | |
| VRALLLLLLLLGLAA | 11 | Q9NZJ5 | |
| RLLLLLLLSLLPVAR | 16 | P32297 | |
| PLLLLLLLLGRRARA | 16 | O14514 | |
| SNPRLLRVALLLLLL | 11 | P09341 | |
| RRARGTPLLLLLLLL | 6 | Q9BZ11 | |
| RPGSRVLLLLLLLLL | 6 | Q9H2A7 | |
| TLLLALLILSLFRRL | 151 | P48546 | |
| LALLVLLVAPPLLRR | 371 | Q9BXJ7 | |
| LLTRLLLDHLRLLAP | 141 | Q9NUS5 | |
| RPAGSRLRLLLLLLL | 6 | P16066 | |
| LLACALLLTLLSLRP | 6 | P23582 | |
| LQLLRSDLRLGRPLL | 21 | P80365 | |
| SNPRLLRVALLLLLL | 11 | P19876 | |
| LRVALLLLLLVAASR | 16 | P19876 | |
| NVRFLLLVLLELPLL | 181 | Q08708 | |
| MRLRLRLLALLLLLL | 1 | Q9NPA2 | |
| RLLALLLLLLAPPAR | 6 | Q9NPA2 | |
| CRLLRTPLATLLLQL | 106 | Q9P2G4 | |
| PASRPRLALLLLLLL | 11 | Q8N729 | |
| RALPRLPLLLLLLLL | 31 | Q02846 | |
| LLRRLQLLMSRLALP | 136 | P20809 | |
| VLSLPQIRLNRLLTI | 926 | Q96RV3 | |
| RLLLSCLLLPAARLA | 11 | A0A1B0GTQ4 | |
| LALRLLNKLLIHLPL | 2021 | O94915 | |
| LLLLLLLLFLILRHR | 471 | Q8N423 | |
| ALRRRLLLLLLVLLI | 6 | Q8IWU2 | |
| RLLAPLLLLCAQQLR | 6 | O14764 | |
| LRLLELPQILQILRA | 201 | A8MYU2 | |
| MSRQLLPVLLLLLLR | 1 | Q13087 | |
| LLLPLLLLLLLRAVL | 11 | Q02818 | |
| LLLLLLRAVLAVPLE | 16 | Q02818 | |
| KILSLLRLLRLSRLI | 381 | Q9Y3Q4 | |
| LLRLLLPHNRLVSLP | 46 | Q96CX6 | |
| LPIRVLLVALILLLA | 66 | Q7L5N7 | |
| LLLLLLLPLRGQANT | 16 | P02747 | |
| LLRLPLLQLLLLVVQ | 11 | Q96AY3 | |
| LLRNIIISLARLPLV | 2391 | P42858 | |
| KILSLLRLLRLSRLI | 261 | O60741 | |
| SNPRLLRVALLLLLL | 11 | P19875 | |
| LRVALLLLLLVAASR | 16 | P19875 | |
| RPAQLLLLQDSLLRL | 736 | Q9Y6J0 | |
| ALRRAPQLLLLLLAA | 11 | Q14393 | |
| RLSLLLLPLLLVQAG | 11 | Q8NEV9 | |
| LLVSLLGLLLLLARS | 16 | Q9NZV1 | |
| QRRLLLLDLLALYTP | 226 | Q96BM1 | |
| SARRPLLLLLLLLLL | 6 | P11279 | |
| ARTLLRLLLRLLLFL | 386 | A6NKP2 | |
| RLLLRLLLFLGLLAL | 391 | A6NKP2 | |
| YLRRLLLLLLLLLLR | 16 | Q9H4B8 | |
| LLLLLLLLLRQPVTR | 21 | Q9H4B8 | |
| VALQLGLRRLLLLLS | 381 | Q9BT04 | |
| LRPRLHFCLVLLLLL | 6 | Q14623 | |
| SRPLLLALLSLALCR | 6 | Q9P2B2 | |
| ARRPQRSLLLLQLLL | 16 | P11717 | |
| RSLLLLQLLLLVAAP | 21 | P11717 | |
| QLISRRPLLLNSVLL | 336 | Q9HCS7 | |
| MRLLPRLLLLLLLVF | 1 | P43307 | |
| RHRRLLLLPLLLFLL | 16 | Q13162 | |
| LFRVLRAALPLQLLL | 8741 | Q8NF91 | |
| RAALPLQLLLLLLIG | 8746 | Q8NF91 | |
| RVVRAALPLQLLLLL | 6831 | Q8WXH0 | |
| VRLRALRLALLILLT | 171 | Q96P88 | |
| RLLLLLLLLLLRHTR | 11 | P04278 | |
| PGLRLALALRLALLL | 16 | B8ZZ34 | |
| LALRALLLLQRLKNR | 816 | Q9Y4R8 | |
| CLVLLLLVLSLRRRL | 676 | Q9C0C4 | |
| LILAVALLRSQPLRS | 21 | C9JXX5 | |
| RALLLQLRLALLVAA | 6 | Q7Z4H8 | |
| LLSLLLPRQNRLRIE | 121 | Q8WWU5 | |
| RQLGRLLLLLRVLDP | 461 | Q9HA65 | |
| THLLRLLRLIILLRI | 191 | P56180 | |
| LLRLLVGLALATLRV | 461 | Q9BSA9 | |
| SRRLLPLLLLLGLAR | 11 | Q6UWL2 | |
| PRSASVLLLLLLLRR | 6 | Q9Y3Q3 | |
| LLLLLRLATLLQSPA | 176 | Q12893 | |
| VSRSPRVRLLLLLLL | 6 | Q96A98 | |
| RVRLLLLLLLLLVVP | 11 | Q96A98 | |
| RTLRLALGLLLLATL | 6 | P16035 | |
| MSPLLRRLLLAALLQ | 1 | P49765 | |
| RRLLLAALLQLAPAQ | 6 | P49765 | |
| LLARPAALTALLLLL | 11 | Q8NBS9 | |
| IFLLILRALQLLTRL | 301 | Q01831 | |
| LRALQLLTRLVLSLQ | 306 | Q01831 | |
| LACLLLLLLLTLPAR | 41 | Q93097 | |
| LRLVPLFVLLALLVL | 51 | Q8IU80 |